Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

TARO PHARMACEUTICAL INDUSTRIES LTD (TAROF) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsMar-31-23Mar-31-22Mar-31-21Mar-31-20Mar-31-19Mar-31-18Mar-31-17Mar-31-16
Revenues573.0561.3549.0644.8669.9661.9879.4950.8
            Revenue growth2.1%2.3%-14.9%-3.8%1.2%-24.7%-7.5%10.2%
Cost of goods sold304.6268.2252.3245.0224.2198.4207.9169.7
Gross profit268.3293.1296.7399.7445.7463.5671.5781.0
            Gross margin46.8%52.2%54.0%62.0%66.5%70.0%76.4%82.1%
Selling, general and administrative    129.5121.9126.5135.9
Sales and marketing98.848.332.931.839.533.740.843.6
Research and development    63.270.470.671.2
EBIT58.792.3-368.4349.5294.3306.8515.2617.5
            EBIT margin10.2%16.4%-67.1%54.2%43.9%46.3%58.6%64.9%
Pre-tax income38.277.9-391.1298.0356.9292.4560.8636.8
Income taxes12.819.69.753.574.782.0103.895.3
            Tax rate33.4%25.2% 17.9%20.9%28.0%18.5%15.0%
Earnings from continuing ops25.458.3-386.7244.2281.8421.9913.71,082.7
Earnings from discontinued ops     -0.3-0.4-0.2
Net income25.458.3-386.7244.2281.8421.6913.41,082.4
            Net margin4.4%10.4%-70.4%37.9%42.1%63.7%103.9%113.9%
 
Diluted EPS$0.68$1.55($10.12)$6.35$7.23$10.51$22.12$25.28
Shares outstanding (diluted)37.637.638.238.539.040.241.342.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy